Business
Sonoma Pharmaceuticals Announces Relaunch of Prescription Dermatology and Eye Care Product Lines in the United States
BOULDER, CO / ACCESSWIRE / November 21, 2024 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented
About this update from Sonoma Pharmaceuticals, Inc.
[{"type":"text","content":"BOULDER, CO / ACCESSWIRE / November 21, 2024 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye, oral and nasal care, dermatological conditions, podiatry, and animal health care, today announced the relaunch of its prescription dermatology and eye care products lines.The prescription-strength products include: Acuicyn® Eyelid & Eyelash Hygiene, Epicyn® Facial Cleanser, Levicyn® Dermal Spray, Levicyn® Gel, Levicyn® Spray Gel and Celacyn® Scar Management Gel. In addition, Lasercyn® Dermal Spray and Lasercyn® Gel are available for over-the-counter use. These hypochlorous acid-based products were previously sold through a distributor to physicians, clinics and pharmacies. The products will now be available directly from Sonoma.\"We are excited to bring back these trusted products and expand our direct offerings for dermatology and eye care,\" said Amy Trombly, CEO of Sonoma. \"These prescription products complement our over-the-counter product line in the U.S., allowing health care professionals and their patients multiple options for effective and safe eye care and scar management, as well as freedom from itch, pain and common skin irritations, including relief following ophthalmological and cosmetic procedures. These products are well-known and well-regarded by physicians across the country, and represent the versatile power of our Microcyn technology.\" All products will be available December 9, 2024 and can be pre-ordered prior to that date. For more information or to place an order, contact our customer service department at 720-452-9690 or [email protected] Sonoma Pharmaceuticals, Inc.Sonoma Pharmaceuticals is a global healthcare leader for developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound, eye, oral and nasal care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. Sonoma's products are clinically proven to reduce itch, pain, scarring, and irritation safely and without damaging healthy tissue. In-vitro and clinical studies of HOCl show it to safely manage skin abrasions, lacerations, minor irritations, cuts, and intact...